How Is The Market Feeling About Iovance Biotherapeutics?
Portfolio Pulse from Benzinga Insights
Iovance Biotherapeutics (NYSE: IOVA) has seen a 3.31% increase in its short percent of float, now at 22.5%. This indicates a bearish sentiment among investors, as it would take 6.68 days to cover the short positions. The company's short interest is higher than its peers, whose average is 13.59%.
July 22, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Iovance Biotherapeutics has experienced a 3.31% increase in its short percent of float, now at 22.5%. This suggests a bearish sentiment among investors, as it would take 6.68 days to cover the short positions. The company's short interest is significantly higher than its peers, whose average is 13.59%.
The increase in short interest indicates that investors are bearish on Iovance Biotherapeutics. The high percentage of shares sold short compared to its peers suggests that the stock may face downward pressure in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100